Literature DB >> 10795350

Beverage-specific alcohol consumption and cirrhosis mortality in a group of English-speaking beer-drinking countries.

W C Kerr1, K M Fillmore, P Marvy.   

Abstract

AIMS: To compare beverage-specific per capita consumption and total alcohol consumption's associations with cirrhosis mortality rates in multiple countries.
DESIGN: Pooled cross-sectional time-series analysis.
SETTING: Australia, Canada, New Zealand, the United Kingdom and the United States during the years 1953-1993. MEASUREMENTS: National level data on per capita total alcohol, beer, wine and spirits consumption and standardized all-cause cirrhosis mortality rates.
FINDINGS: Significant associations with cirrhosis mortality are found for both total ethanol and spirits. Spirits consumption is found to make up the majority of the effect of alcoholic beverage consumption on cirrhosis mortality and the model including only spirits is found to fit the data at least as well as the model including only total ethanol consumption. The lag relationship between all alcohol types and cirrhosis is found to be short with only present and 1 year's lagged consumption having significant associations.
CONCLUSIONS: Spirits consumption rather than beer or wine is associated with cirrhosis mortality in this group of primarily beer-drinking countries. This finding offers important clues to understanding the drinking behaviors associated with cirrhosis mortality on the individual level.

Entities:  

Mesh:

Year:  2000        PMID: 10795350     DOI: 10.1046/j.1360-0443.2000.9533394.x

Source DB:  PubMed          Journal:  Addiction        ISSN: 0965-2140            Impact factor:   6.526


  14 in total

1.  Risk factors for alcoholic liver disease in China.

Authors:  Xiao-Lan Lu; Jin-Yan Luo; Ming Tao; Yan Gen; Ping Zhao; Hong-Li Zhao; Xiao-Dong Zhang; Nei Dong
Journal:  World J Gastroenterol       Date:  2004-08-15       Impact factor: 5.742

2.  Alcohol and liver cirrhosis mortality in the United States: comparison of methods for the analyses of time-series panel data models.

Authors:  Yu Ye; William C Kerr
Journal:  Alcohol Clin Exp Res       Date:  2010-10-06       Impact factor: 3.455

Review 3.  Clinical differences between alcoholic liver disease and nonalcoholic fatty liver disease.

Authors:  Nobuyuki Toshikuni; Mikihiro Tsutsumi; Tomiyasu Arisawa
Journal:  World J Gastroenterol       Date:  2014-07-14       Impact factor: 5.742

4.  Per capita alcohol consumption and ischemic heart disease mortality in a panel of US states from 1950 to 2002.

Authors:  William C Kerr; Katherine Karriker-Jaffe; Meenakshi Subbaraman; Yu Ye
Journal:  Addiction       Date:  2010-11-09       Impact factor: 6.526

5.  Alcohol consumption and liver disease in Australia: a time series analysis of the period 1935-2006.

Authors:  Heng Jiang; Michael Livingston; Robin Room; Paul Dietze; Thor Norström; William C Kerr
Journal:  Alcohol Alcohol       Date:  2013-09-19       Impact factor: 2.826

6.  Alcoholic liver disease.

Authors:  Radan Bruha; Karel Dvorak; Jaromir Petrtyl
Journal:  World J Hepatol       Date:  2012-03-27

7.  Per capita alcohol consumption and suicide mortality in a panel of US states from 1950 to 2002.

Authors:  William C Kerr; Meenakshi Subbaraman; Yu Ye
Journal:  Drug Alcohol Rev       Date:  2011-09

8.  Alcoholic liver disease in Nepal: identifying homemade alcohol as a culprit.

Authors:  Bickram Pradhan; Antoine Hadengue; François Chappuis; Shatdal Chaudhary; Dharanidhar Baral; Pascal Gache; Prahlad Karki; Suman Rijal
Journal:  Clin Exp Gastroenterol       Date:  2015-07-13

9.  Characterizing the epidemiological transition in Mexico: national and subnational burden of diseases, injuries, and risk factors.

Authors:  Gretchen Stevens; Rodrigo H Dias; Kevin J A Thomas; Juan A Rivera; Natalie Carvalho; Simón Barquera; Kenneth Hill; Majid Ezzati
Journal:  PLoS Med       Date:  2008-06-17       Impact factor: 11.069

10.  Liver cirrhosis mortality in 187 countries between 1980 and 2010: a systematic analysis.

Authors:  Ali A Mokdad; Alan D Lopez; Saied Shahraz; Rafael Lozano; Ali H Mokdad; Jeff Stanaway; Christopher J L Murray; Mohsen Naghavi
Journal:  BMC Med       Date:  2014-09-18       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.